Connecticut et al v. Aurobindo Pharma USA, Inc. et al

  1. March 01, 2017

    20 More States Join Generic Drug-Pricing Antitrust Action

    Forty states are now bringing antitrust claims against six generic-drug makers including Heritage, Mylan and Teva, alleging they conspired to fix the prices of an antibiotic and a diabetes medication, according to an amended complaint filed in Connecticut federal court Wednesday.

  2. February 09, 2017

    Feds Look To Intervene In 20-State Drug Antitrust Suit

    The U.S. government on Thursday asked a Connecticut federal court for permission to intervene in an antitrust action from 20 states against six generic-drug makers including Heritage, Mylan and Teva, citing the need to "protect the integrity" of its own investigation into the generic pharmaceutical industry.

  3. December 15, 2016

    20 States Sue Generic-Drug Companies Over Collusion

    Twenty states announced Thursday they have filed a lawsuit against generic-drug makers including Heritage, Teva, Mylan and three others alleging the companies conspired to fix prices and constrain competition for antibiotics and diabetes treatments.